Ligand validation:2XCV

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 2XCV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2XCV_IMP_A_1491	91%	17%	0.099	0.986	1.66	1.94	3	7	2	0	100%	1
2XCW_IMP_A_1490	89%	22%	0.101	0.982	1.64	1.57	3	5	2	0	100%	1
6DDH_IMP_A_601	71%	23%	0.11	0.929	1.59	1.59	2	4	0	0	100%	1
9AUV_IMP_E_801	100%	61%	0.028	0.992	0.78	0.7	-	-	0	0	100%	1
8QWA_IMP_A_501	100%	47%	0.038	0.987	1.01	1.04	3	3	0	0	100%	1
9HG2_IMP_E_501	100%	63%	0.039	0.988	0.65	0.76	-	-	0	0	100%	1
9DC8_IMP_A_801	100%	57%	0.041	0.985	0.82	0.83	-	-	0	0	100%	1
9HFZ_IMP_A_501	100%	64%	0.041	0.984	0.6	0.78	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.